Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG raised Praxis Precision Medicines Inc (NASDAQ
RAX) price target from $507 to $843. BTIG analyst Kambiz…Continue reading...